FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to the chemical-pharmaceutical industry and represents a method for producing microcapsules possessing supramolecular properties by non-solvent addition differing by the fact that a microcapsule nucleus is trivitamin dissolved in dimethylsulphoxide, whereas a coating is xanthan gum deposited from a butanol solution by adding toluene as a non-solvent and water, which is followed by drying at room temperature.
EFFECT: invention provides facilitating the preparation microencapsulation in water-soluble polymers and higher weight yield.
4 ex, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF SEL-PLEX ENCAPSULATION | 2013 |
|
RU2538663C1 |
METHOD OF OBTAINING FENBENDAZOLE MICROCAPSULES, POSSESSING SUPRAMOLECULAR PROPERTIES | 2013 |
|
RU2538805C1 |
METHOD FOR PRODUCING SEL-PLEX NANOCAPSULES POSSESSING SUPRAMOLECULAR PROPERTIES | 2014 |
|
RU2556118C1 |
FENBENDAZOLE ENCAPSULATION METHOD | 2013 |
|
RU2544177C2 |
METHOD OF OBTAINING PARTICLES OF MICROCAPSULATED ANTISEPTIC DOROGOV'S STIMULATOR (ADS) 2 FRACTION IN XANTHAN GUM, POSSESSING SUPRAMOLECULAR PROPERTIES | 2013 |
|
RU2537253C1 |
METHOD FOR FENBENDAZOLE ENCAPSULATION | 2013 |
|
RU2537249C1 |
METHOD OF SEL-PLEX ENCAPSULATION | 2014 |
|
RU2567342C2 |
METHOD OF FENBENDAZOLE ENCAPSULATION | 2013 |
|
RU2544167C2 |
FENBENDAZOLE ENCAPSULATION METHOD | 2013 |
|
RU2547558C2 |
METHOD FOR FENBENDAZOLE ENCAPSULATION | 2013 |
|
RU2548738C2 |
Authors
Dates
2015-04-20—Published
2013-08-27—Filed